SelectQuote director Devine buys $14,460 in stock

Published 19/03/2025, 21:58
SelectQuote director Devine buys $14,460 in stock

In a recent transaction disclosed by SelectQuote, Inc. (NYSE:SLQT), Director Denise L. Devine purchased 4,000 shares of the company’s common stock. The shares were acquired on March 14, 2025, at a price of $3.615 per share, totaling $14,460. The timing appears strategic, as InvestingPro data shows the stock has gained over 100% in the past year, with particularly strong momentum in recent months. Following this transaction, Devine’s direct ownership in SelectQuote amounts to 318,583 shares. This acquisition reflects ongoing confidence in the company’s prospects by its board members, as SelectQuote continues to navigate the insurance brokerage industry. With a market capitalization of $619 million and analyst price targets ranging from $7-8, InvestingPro analysis suggests the stock is currently undervalued. Get access to the full SelectQuote research report and 10+ additional ProTips with an InvestingPro subscription.

In other recent news, SelectQuote, Inc. has reported fiscal second-quarter earnings that exceeded analyst expectations, leading to a positive outlook for the company. The company posted adjusted earnings per share of $0.30, surpassing the consensus estimate of $0.09. Revenue increased by 18.7% year-over-year to $481.1 million, beating the projected $441.5 million. This growth was driven by strong performances across various business segments, including a 3% revenue increase in the Senior division and a 64% rise in the Healthcare Services (NASDAQ:HCSG) segment. Additionally, SelectQuote raised its fiscal 2025 revenue guidance to between $1.5 billion and $1.575 billion, above the previous analyst consensus of $1.46 billion.

In a strategic move, SelectQuote completed a $350 million preferred stock sale involving entities associated with Morgan Stanley (NYSE:MS) and Bain Capital. The transaction included the sale of 350,000 shares of Senior Non-Convertible Preferred Stock and 30,833,333 warrants to purchase common stock. This investment aims to enhance the company’s financial position and provide greater operational flexibility. Furthermore, SelectQuote expanded its board of directors by appointing Srdjan Vukovic and Christopher Wolfe, bringing expertise in private equity and insurance. These developments reflect SelectQuote’s efforts to strengthen its financial and governance structures as it navigates the competitive insurance brokerage industry.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.